804 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
in the company’s pipeline, expectations with respect to the company’s future market position and the projected benefits of the company’s alliances … , collaborations, acquisitions, divestitures, alliances and other portfolio actions and the failure to achieve anticipated benefits from
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
Benefits Business of CVS Caremark Former Executive Vice President of Global Services and CFO of Eli Lilly and Company Director since 2020 Committees
8-K
EX-99.1
z4wjbw1bhxgfecf
18 Mar 24
Strengthening Neuroscience Portfolio
8:56am
SC TO-T/A
EX-99
upobcche184ic1
23 Feb 24
Third party tender offer statement (amended)
7:34am
8-K
EX-4.1
7aakxytiuz7ny6wmpz7g
22 Feb 24
Other Events
4:15pm
8-K
EX-1.1
uw0 5iwll
22 Feb 24
Other Events
4:15pm
424B5
9kxca707
16 Feb 24
Prospectus supplement for primary offering
4:34pm
424B2
6er1gr7 dcvrlf
13 Feb 24
Prospectus for primary offering
8:00am